Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
oleh: Carine M. Lama, MS, Miguel A. Hernandez-Rovira, BSc, Neha Mehta-Shah, MD, Aaron Russell, MD, Amy C.M. Musiek, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-08-01 |
Deskripsi
Subjek
cutaneous T-cell lymphoma; Janus kinase inhibitor; mogamulizumab-associated rash; Sézary syndrome